Latest advances in gene therapy for ocular disease are highlighted in Human Gene Therapy

Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body. A series of articles available online ahead of print in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., highlight several exciting developments in ocular gene therapy. The articles are available free online at www.liebertpub.com/hum

Read the whole article on Physorg

More from Physorg